Collplant Biotechnologies Ltd
NASDAQ:CLGN
Collplant Biotechnologies Ltd
Revenue
Collplant Biotechnologies Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Revenue
$11m
|
CAGR 3-Years
21%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Kamada Ltd
NASDAQ:KMDA
|
Revenue
$142.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Revenue
$4.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Revenue
$82.7m
|
CAGR 3-Years
91%
|
CAGR 5-Years
136%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Revenue
₪0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Collplant Biotechnologies Ltd
Revenue Breakdown
Breakdown by Geography
Collplant Biotechnologies Ltd
Total Revenue:
11m
USD
|
United States:
10.8m
USD
|
Canada:
87k
USD
|
Europe And Other:
28k
USD
|
Israel:
5k
USD
|
Breakdown by Segments
Collplant Biotechnologies Ltd
See Also
What is Collplant Biotechnologies Ltd's Revenue?
Revenue
11m
USD
Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Revenue amounts to 11m USD.
What is Collplant Biotechnologies Ltd's Revenue growth rate?
Revenue CAGR 5Y
17%
Over the last year, the Revenue growth was 3 553%. The average annual Revenue growth rates for Collplant Biotechnologies Ltd have been 21% over the past three years , 17% over the past five years .